Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'SROUR EF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 100 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Srour, EF; Jetmore, A; Wolber, FM; Plett, PA; Abonour, R; Yoder, MC; Orschell-Traycoff, CM
      Homing, cell cycle kinetics and fate of transplanted hematopoietic stem cells

      LEUKEMIA
    2. Abonour, R; Williams, DA; Einhorn, L; Hall, KM; Chen, J; Coffman, J; Traycoff, CM; Bank, A; Kato, I; Ward, M; Williams, SD; Hromas, R; Robertson, MJ; Smith, FO; Woo, D; Mills, B; Srour, EF; Cornetta, K
      Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells

      NATURE MEDICINE
    3. Wilpshaar, J; Falkenburg, JHF; Tong, X; Noort, WA; Breese, R; Heilman, D; Kanhai, H; Orschell-Traycoff, CM; Srour, EF
      Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice

      BLOOD
    4. Orschell-Traycoff, CM; Hiatt, K; Dagher, RN; Rice, S; Yoder, MC; Srour, EF
      Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle

      BLOOD
    5. Srour, EF
      Proliferative history and hematopoietic function of ex vivo expanded humanCD34(+) cells

      BLOOD
    6. Srour, EF; Abonour, R; Cornetta, K; Traycoff, CM
      Ex vivo expansion of hematopoietic stem and progenitor cells: Are we thereyet?

      JOURNAL OF HEMATOTHERAPY
    7. Pyatt, RE; Jenski, LL; Allen, R; Cornetta, K; Abonour, R; Traycoff, CM; Srour, EF
      Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells

      JOURNAL OF HEMATOTHERAPY
    8. Reddy, JA; Haneline, LS; Srour, EF; Antony, AC; Clapp, DW; Low, PS
      Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells

      BLOOD
    9. HALSTEAD BW; TONG X; TRAYCOFF CM; SROUR EF
      PROLIFERATION KINETICS AND LENGTH OF CELL-CYCLE OF INDIVIDUAL LONG-TERM CULTURE INITIATING CELLS (LTC-IC)

      Experimental hematology
    10. TONG X; SROUR EF
      TGF-BETA SUPPRESSES CELL-DIVISION OF G(0)CD34(+) CELLS WHILE MAINTAINING PRIMITIVE HEMATOPOIETIC POTENTIAL

      Experimental hematology
    11. TONG X; CORNETTA K; TRAVCOFF CM; SROUR EF
      HIGH-SPEED CENTRIFUGATION ENHANCES EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO MITOTICALLY QUIESCENT HUMAN HEMATOPOIETIC PROGENITOR CELLS

      Experimental hematology
    12. TRAVCOFF CM; DAGHER R; YODER MC; HIATT K; SROUR EF
      MARROW REPOPULATING ABILITY OF SCA-1(- CELLS FRACTIONATED ON THE BASIS OF ADHESION MOLECULE EXPRESSION AND POSITION IN CELL-CYCLE() LIN)

      Experimental hematology
    13. SHOUFLER DW; TRAYCOFF CM; SROUR EF
      CELL-CYCLE REGULATION IN G(O)CD34-VITRO IN RESPONSE TO CYTOKINE STIMULATION( CELLS PROLIFERATING IN)

      Experimental hematology
    14. GOTHOT A; PYATT R; MCMAHEL J; RICE S; SROUR EF
      ASSESSMENT OF PROLIFERATIVE AND COLONY-FORMING CAPACITY AFTER SUCCESSIVE IN-VITRO DIVISIONS OF SINGLE HUMAN CD34(+) CELLS INITIALLY ISOLATED IN G(0)

      Experimental hematology
    15. TRAYCOFF CM; ORAZI A; LADD AC; RICE S; MCMAHEL J; SROUR EF
      PROLIFERATION-INDUCED DECLINE OF PRIMITIVE HEMATOPOIETIC PROGENITOR-CELL ACTIVITY IS COUPLED WITH AN INCREASE IN APOPTOSIS OF EX-VIVO EXPANDED CD34(+) CELLS

      Experimental hematology
    16. CORNETTA K; GHARPURE V; MILLS B; HROMAS R; ABONOUR R; BROUN ER; TRAYCOFF CM; HANNA M; WYMAN N; DANIELSON C; GONIN R; KUNKEL L; OLDHAM F; SROUR EF
      RAPID ENGRAFTMENT AFTER ALLOGENEIC TRANSPLANTATION USING CD34-ENRICHED MARROW-CELLS

      Bone marrow transplantation
    17. Abonour, R; Scott, KM; Kunkel, LA; Robertson, MJ; Hromas, R; Graves, V; Lazaridis, EN; Cripe, L; Gharpure, V; Traycoff, CM; Mills, B; Srour, EF; Cornetta, K
      Autologous transplantation of mobilized peripheral blood CD34(+) cells selected by immunomagnetic procedures in patients with multiple myeloma

      BONE MARROW TRANSPLANTATION
    18. ZHANG YY; VIK TA; RYDER JW; SROUR EF; JACKS T; SHANNON K; CLAPP DW
      NF1 REGULATES HEMATOPOIETIC PROGENITOR-CELL GROWTH AND RAS SIGNALING IN RESPONSE TO MULTIPLE CYTOKINES

      The Journal of experimental medicine
    19. VAZ F; SROUR EF; ALMEIDAPORADA G; ASCENSAO JL
      HUMAN THYMIC STROMA SUPPORTS HUMAN NATURAL-KILLER (NK) CELL-DEVELOPMENT FROM IMMATURE PROGENITORS

      Cellular immunology (Print)
    20. TRAYCOFF CM; HALSTEAD B; RICE S; MCMAHEL J; SROUR EF; CORNETTA K
      CHRONIC MYELOGENOUS LEUKEMIA CD34(-CYCLE MORE RAPIDLY THAN NORMAL MARROW CD34(+) CELLS() CELLS EXIT G(0)G(1) PHASES OF CELL)

      British Journal of Haematology
    21. CHABANNON C; CORNETTA K; LOTZ JP; ROSENFELD C; SHLOMCHIK M; YANOVITCH S; MAROLLEAU JP; SLEDGE G; NOVAKOVITCH G; SROUR EF; BURTNESS B; CAMERLO J; GRAVIS G; LEEFISCHER J; FAUCHER C; CHABBERT I; KRAUSE D; MARANINCHI D; MILLS B; KUNKEL L; OLDHAM F; BLAISE D; VIENS P
      HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL)

      British Journal of Cancer
    22. GOTHOT A; VANDERLOO JCM; CLAPP DW; SROUR EF
      CELL CYCLE-RELATED CHANGES IN REPOPULATING CAPACITY OF HUMAN MOBILIZED PERIPHERAL-BLOOD CD34(-DEFICIENT MICE() CELLS IN NONOBESE DIABETIC SEVERE COMBINED IMMUNE)

      Blood
    23. VEENA P; TRAYCOFF CM; WILLIAMS DA; MCMAHEL J; RICE S; CORNETTA K; SROUR EF
      DELAYED TARGETING OF CYTOKINE-NONRESPONSIVE HUMAN BONE-MARROW CD34(-MEDIATED GENE-TRANSFER ENHANCES TRANSDUCTION EFFICIENCY AND LONG-TERM EXPRESSION OF TRANSDUCED GENES() CELLS WITH RETROVIRUS)

      Blood
    24. TRAYCOFF CM; SROUR EF; DUTT P; FAN Y; CORNETTA K
      THE 30 35 KDA CHYMOTRYPTIC FRAGMENT OF FIBRONECTIN ENHANCES RETROVIRAL-MEDIATED GENE-TRANSFER IN PURIFIED CHRONIC MYELOGENOUS LEUKEMIA BONE-MARROW PROGENITORS/

      Leukemia
    25. TRAYCOFF CM; YODER MC; HIATT K; SROUR EF
      FUNCTIONAL ASSOCIATION BETWEEN EXPRESSION OF ADHESION MOLECULES AND MARROW REPOPULATING POTENTIAL OF PRIMITIVE MURINE HEMATOPOIETIC PROGENITOR CELLS (HPC)

      Experimental hematology
    26. TRAYCOFF CM; YODER MC; HIATT K; SROUR EF
      REENTRY OF EX-VIVO EXPANDED SCA-1(+) CELLS INTO MITOTIC QUIESCENCE ISNOT SUFFICIENT FOR THE RESTORATION OF PRIMITIVE HEMATOPOIETIC POTENTIAL

      Experimental hematology
    27. GOTHOT A; FINK C; VANDERLOO JCM; CLAPP DW; SROUR EF
      SEPARATION OF NOD-SCID MOUSE DEPOPULATING CELLS BY CELL-CYCLE FRACTIONATION OF HUMAN CD34-33342 AND PYRONIN( CELLS WITH HOECHST)

      Experimental hematology
    28. VEENA P; CORNETTA K; DAVIDSON A; AGUERO B; MCMAHEL J; TRAYCOFF CM; SROUR EF
      PREFERENTIAL SEQUESTRATION IN-VITRO OF BCR ABL-NEGATIVE HEMATOPOIETICPROGENITOR CELLS AMONG CYTOKINE NONRESPONSIVE CML-MARROW CD34(+) CELLS/

      Bone marrow transplantation
    29. PONNAZHAGAN S; MUKHERJEE P; WANG XS; QING KY; KUBE DM; MAH C; KURPAD C; YODER MC; SROUR EF; SRIVASTAVA A
      ADENOASSOCIATED VIRUS TYPE 2-MEDIATED TRANSDUCTION IN PRIMARY HUMAN BONE-MARROW-DERIVED CD34(- DONOR VARIATION AND CORRELATION OF TRANSGENEEXPRESSION WITH CELLULAR-DIFFERENTIATION() HEMATOPOIETIC PROGENITOR CELLS )

      Journal of virology
    30. LADD AC; PYATT R; GOTHOT A; RICE S; MCMAHEL J; TRAYCOFF CM; SROUR EF
      ORDERLY PROCESS OF SEQUENTIAL CYTOKINE STIMULATION IS REQUIRED FOR ACTIVATION AND MAXIMAL PROLIFERATION OF PRIMITIVE HUMAN BONE-MARROW CD34(+) HEMATOPOIETIC PROGENITOR CELLS RESIDING IN G(0)

      Blood
    31. GOTHOT A; PYATT R; MCMAHEL J; RICE S; SROUR EF
      FUNCTIONAL-HETEROGENEITY OF HUMAN CD34(+) CELLS ISOLATED IN SUBCOMPARTMENTS OF THE G(0) G(1) PHASE OF THE CELL-CYCLE/

      Blood
    32. GOTHOT A; FINK C; VANDERLOO JCM; CLAPP DW; SROUR EF
      DETERMINATION OF THE CELL-CYCLE STATUS OF NOD SCID MOUSE REPOPULATINGCELLS IN FRESHLY ISOLATED OR EX-VIVO STIMULATED MOBILIZED PERIPHERAL-BLOOD CD34+ CELLS/

      Blood
    33. HALSTEAD B; MCMAHEL J; RICE S; SROUR EF; TRAYCOFF CM
      DEFINING CELLULAR INTERACTIONS CONDUCIVE FOR THE PRESERVATION OF HEMATOPOIETIC FUNCTION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS

      Blood
    34. TRAYCOFF CM; YODER MC; HIATT K; SROUR EF
      BONE-MARROW REPOPULATING POTENTIAL OF SCA-1(- CELLS FRACTIONATED ON THE BASIS OF ADHESION MOLECULE EXPRESSION() LIN)

      Blood
    35. ORAZI A; HROMAS RA; NEIMAN RS; GREINER TC; LEE CH; RUBIN L; HASKINS S; HEEREMA NA; GHARPURE V; ABONOUR R; SROUR EF; CORNETTA K
      POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN BONE-MARROW TRANSPLANT RECIPIENTS ARE AGGRESSIVE DISEASES WITH A HIGH-INCIDENCE OF ADVERSE HISTOLOGIC AND IMMUNOBIOLOGICAL FEATURES

      American journal of clinical pathology
    36. SROUR EF; BREGNI M; TRAYCOFF CM; ERO BA; KOSAK ST; HOFFMAN R; SIENA S; GIANNI AM
      LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS ARE MORE ABUNDANT INMOBILIZED PERIPHERAL-BLOOD GRAFTS THAN IN BONE-MARROW BUT HAVE A MORELIMITED EX-VIVO EXPANSION POTENTIAL

      Blood cells, molecules, & diseases
    37. CORNETTA K; SROUR EF; MOORE A; DAVIDSON A; BROUN ER; HROMAS R; MOEN RC; MORGAN RA; RUBIN L; ANDERSON WF; HOFFMAN R; TRICOT G
      RETROVIRAL GENE-TRANSFER IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE-LEUKEMIA

      Human gene therapy
    38. LADD AC; PYATT R; TRAYCOFF CM; SROUR EF
      ORDERLY PROCESS OF SEQUENTIAL CYTOKINE STIMULATION IS REQUIRED FOR ACTIVATION AND MAXIMAL PROLIFERATION OF PRIMITIVE HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS RESIDING IN G0

      Experimental hematology
    39. GOTHOT A; PYATT R; MCMAHEL J; GRIGSBY S; SROUR EF
      ACTIVATION AND PROLIFERATION KINETICS OF SINGLE QUIESCENT CD34+ CELLSRESIDING IN G0

      Experimental hematology
    40. GOTHOL A; PYATT R; MCMAHEL J; GRIGSBY S; SROUR EF
      REENTRY OF CD34-VITRO PROLIFERATION IS NOT SUFFICIENT FOR THE RESTORATION OF PRIMITIVE HEMATOPOIETIC POTENTIAL( CELLS INTO MITOTIC QUIESCENCE FOLLOWING IN)

      Experimental hematology
    41. TRAYCOFF CM; FAN Y; MCMAHEL J; SROUR EF; CORNETTA K
      ENRICHMENT OF MDR-POSITIVE HUMAN PROGENITORS BY FLOW CYTOMETRIC CELL SORTING FOLLOWING RETROVIRAL-MEDIATED GENE-TRANSFER OF THE HUMAN MDR1 GENE

      Experimental hematology
    42. TRAYCOFF CM; SROUR EF
      RECIPROCAL CHANGES IN FAS AND BCL2 EXPRESSION MAY BE RESPONSIBLE FOR THE INCREASED APOPTOSIS OBSERVED IN DIVIDING CD34+ CELLS

      Experimental hematology
    43. TRAYCOFF CM; CORNETTA K; YODER MC; DAVIDSON A; SROUR EF
      EX-VIVO EXPANSION OF MURINE HEMATOPOIETIC PROGENITOR CELLS GENERATES CLASSES OF EXPANDED CELLS POSSESSING DIFFERENT LEVELS OF BONE-MARROW REPOPULATING POTENTIAL

      Experimental hematology
    44. LEEMHUIS T; YODER MC; GRIGSBY S; AGUERO B; EDER P; SROUR EF
      ISOLATION OF PRIMITIVE HUMAN BONE-MARROW HEMATOPOIETIC PROGENITOR CELLS USING HOECHST-33342 AND RHODAMINE-123

      Experimental hematology
    45. RIGDEN JP; CORNETTA K; SROUR EF; HANNA M; BROUN ER; HROMAS R; BAUTE J; HILTON J; COX E; RUBIN L; GONIN R; TRICOT G
      MINIMIZING GRAFT-REJECTION IN ALLOGENEIC T-CELL-DEPLETED BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    46. PONNAZHAGAN S; MUKHERJEE P; WANG XS; KURPAD C; YODER MC; SROUR EF; SRIVASTAVA A
      ADENOASSOCIATED VIRUS 2-MEDIATED TRANSDUCTION OF PRIMARY HUMAN BONE-MARROW-DERIVED CD34- DONOR VARIATION AND CORRELATION OF EXPRESSION WITHCELLULAR-DIFFERENTIATION( HEMATOPOIETIC PROGENITOR CELLS )

      Blood
    47. VEENA P; CORNETTA K; WILLIAMS DA; TRAYCOFF CM; MCMAHEL J; SROUR EF
      DELAYED TARGETING OF CYTOKINE NONRESPONSIVE CELLS WITH RETROVIRUS-MEDIATED GENE-TRANSFER ENHANCES TRANSDUCTION EFFICIENCY AND PERSISTENCE OF LONG-TERM EXPRESSION OF TRANSDUCED GENES

      Blood
    48. TRAYCOFF CM; YODER MC; HIATT K; SROUR EF
      CELL-CYCLE STAGE-SPECIFIC EXPRESSION OF ADHESION MOLECULES MAY AUGMENT ENGRAFTMENT POTENTIAL OF QUIESCENT BUT NOT MITOTICALLY ACTIVE HEMATOPOIETIC PROGENITOR CELLS

      Blood
    49. CORNETTA K; MILLS B; HANNA M; GHARPURE V; HROMAS R; ABONOUR R; ROBERTSON M; BROUN ER; COX E; WYMAN N; MENKE C; BAUTE J; GONIN R; KUNKEL L; OLDHAM F; SROUR EF
      ALLOGENEIC BONE-MARROW TRANSPLANTATION USING CD34 ENRICHED CELLS

      Blood
    50. SROUR EF; TRAYCOFF CM
      MOBILIZATION OF PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS INTO THE PERIPHERY MAY INVOLVE THEIR EXIT FROM THE BONE-MARROW MICROENVIRONMENT WITHOUT ENTRY INTO ACTIVE PHASES OF CELL-CYCLE

      Blood
    51. GOTHOT A; PYATT R; MCMAHEL J; GRIGSBY S; SROUR EF
      THE HEMATOPOIETIC POTENTIAL OF CD34+ CELLS IS DIRECTLY RELATED TO THEIR POSITION WITHIN THE G0 G1 PHASE OF CELL-CYCLE/

      Blood
    52. MCCARTHY LJ; DANIELSON CFM; CORNETTA K; SROUR EF; BROUN ER
      AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Critical reviews in clinical laboratory sciences
    53. DERIGS HG; MORGAN DA; HOFFMAN R; LITZ SL; SROUR EF; BRANDT JE; BOSWELL HS
      AP-1 C-JUN AND C-MYC REGULATION DURING MEGAKARYOCYTIC DIFFERENTIATIONOF A HUMAN BI-POTENTIAL GROWTH-FACTOR-DEPENDENT CELL-LINE

      Platelets
    54. TRAYCOFF CM; ORAZI A; GRIGSBY S; SROUR EF
      PROLIFERATION-INDUCED DECLINE OF PRIMITIVE HEMATOPOIETIC PROGENITOR-CELL ACTIVITY CORRELATES WITH AN ASSOCIATED INCREASE IN THE PERCENTAGE OF APOPTOTIC EX-VIVO EXPANDED CD34(+) CELLS

      Experimental hematology
    55. PYATT R; JENSKI LJ; COMETTA K; GRIGSBY S; TRAYCOFF CM; SROUR EF
      USE OF MEROCYANINE-540 FOR THE ISOLATION OF QUIESCENT PRIMITIVE HUMANBONE-MARROW HEMATOPOIETIC PROGENITOR CELLS

      Experimental hematology
    56. SROUR EF; CORNETTA K; YODER M; DAVIDSON A; TRAYCOFF CM
      EX-VIVO EXPANSION OF MURINE HEMATOPOIETIC PROGENITOR CELLS GENERATES CLASSES OF EXPANDED CELLS POSSESSING VARYING LEVELS OF BONE-MARROW REPOPULATING POTENTIALS

      Experimental hematology
    57. CHEATHAM A; PYATT R; GRIGSBY S; MCMAHEL J; MANTEL C; TRAYCOFF CM; SROUR EF
      ISOLATION OF HUMAN BONE-MARROW CD34(-CYCLE USING DNA STAINING WITH HOECHST-33342 AND RNA LABELING WITH PYRONIN-Y() CELLS RESIDING IN GO PHASE OF CELL)

      Experimental hematology
    58. TRAYCOFF CM; SROUR EF; CORNETTA K
      INCREASED CELL-CYCLE ACTIVITY OF CHRONIC MYELOID-LEUKEMIA (CML) CD34-DEGREE OF RETROVIRAL-MEDIATED GENE-TRANSFER (RMGT) IN CML PROGENITORS(CELLS MAY EXPLAIN THE HIGH)

      Experimental hematology
    59. TRAYCOFF CM; SROUR EF; DITT P; CORNETTA K
      THE 30 35 KD CHYMOTRYPTIC FRAGMENT OF FIBRONECTIN ENHANCES RETROVIRAL-MEDIATED GENE-TRANSFER (RMGT) IN CHRONIC MYELOGENOUS LEUKEMIA (CML) CD34+ HLA-DR+ AND CD34+ HLA-DR- BONE-MARROW PROGENITORS/

      Experimental hematology
    60. TRAYCOFF CM; CHEATHAM A; WILLIAMS DA; CORNETTA K; SROUR EF
      RETROVIRAL-MEDIATED GENE-TRANSFER (RMGT) INTO PRIMITIVE HEMATOPOIETICPROGENITOR CELLS CAPABLE OF LONG-TERM IN-VITRO HEMATOPOIESIS REQUIRESPRESTIMULATION FOR 5 TO 6 DAYS

      Experimental hematology
    61. LAVER J; TRAYCOFF CM; ABDELMAGEED A; GEE A; LEE C; TURNER C; SROUR EF; ABBOUD M
      EFFECTS OF CD34(-CELL IMMUNODEPLETION ON CORD-BLOOD HEMATOPOIETIC PROGENITORS - RELEVANCE TO STEM-CELL TRANSPLANTATION() SELECTION AND T)

      Experimental hematology
    62. PAYNE TA; TRAYCOFF CM; LAVER J; XU F; SROUR EF; ABBOUD MR
      PHENOTYPIC ANALYSIS OF EARLY HEMATOPOIETIC PROGENITORS IN CORD-BLOOD AND DETERMINATION OF THEIR CORRELATION WITH CLONOGENIC PROGENITORS - RELEVANCE TO CORD-BLOOD STEM-CELL TRANSPLANTATION

      Bone marrow transplantation
    63. ZANJANI ED; SROUR EF; HOFFMAN R
      RETENTION OF LONG-TERM REPOPULATING ABILITY OF XENOGENEIC TRANSPLANTED PURIFIED ADULT HUMAN BONE-MARROW HEMATOPOIETIC STEM-CELLS IN SHEEP

      The Journal of laboratory and clinical medicine
    64. VEENA P; DAVIDSON A; TRAYCOFF CM; CORNETTA K; SROUR EF
      PREFERENTIAL SEQUESTRATION IN-VITRO OF BENIGN HEMATOPOIETIC PROGENITOR CELLS AMONG CYTOKINE NON RESPONSIVE CML MARROW CD34+ CELLS

      Blood
    65. CORNETTA K; GHARPURE V; HROMAS R; ABONOUR R; BROUN ER; COX E; WYMAN N; MENKE C; BAUTE J; MILLS B; OLDHAM F; SROUR EF
      SIBLING-MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION USING CD34 CELLS OBTAINED BY IMMUNOMAGNETIC BEAD SEPARATION

      Blood
    66. LADD AC; PYATT R; GRIGSBY S; MCMAHEL J; TRAYCOFF CM; SROUR EF
      ACTIVATION AND PROLIFERATION OF PRIMITIVE HUMAN HEMATOPOIETIC PROGENITOR CELLS RESIDING IN G(0) FOLLOWS AN ORDERLY PROCESS WHICH REQUIRES SEQUENTIAL CYTOKINE STIMULATION

      Blood
    67. TRAYCOFF CM; KOSAK ST; GRIGSBY S; SROUR EF
      EVALUATION OF EX-VIVO EXPANSION POTENTIAL OF CORD-BLOOD AND BONE-MARROW HEMATOPOIETIC PROGENITOR CELLS USING CELL TRACKING AND LIMITING DILUTION ANALYSIS

      Blood
    68. CORNETTA K; BEREBITSKY D; BEHNIA M; TRAYCOFF C; SROUR EF; SLEDGE GW
      A RETROVIRAL SECTOR EXPRESSING HUMAN INTERFERON-GAMMA UP-REGULATES MHC ANTIGEN EXPRESSION IN HUMAN BREAST-CANCER AND LEUKEMIA-CELL LINES

      Cancer gene therapy
    69. TONG J; GIANNI AM; SIENA S; SROUR EF; BREGNI M; HOFFMAN R
      PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS ARE PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS

      Blood cells
    70. TRAYCOFF CM; ABBOUD MR; LAVER J; CLAPP DW; HOFFMAN R; LAW P; SROUR EF
      HUMAN UMBILICAL-CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS - ARE THEY THE SAME AS THEIR ADULT BONE-MARROW COUNTERPARTS

      Blood cells
    71. TRAYCOFF CM; KOSAK ST; SROUR EF
      ASSESSMENT OF THE EX-VIVO EXPANSION POTENTIAL OF UMBILICAL-CORD BLOODAND BONE-MARROW LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS

      Experimental hematology
    72. LEEMHUIS T; GRIGSBY S; EDER P; SROUR EF
      ISOLATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS FROM HUMAN BONE-MARROW BY SELECTING FOR CD34+, HOECHST(DIM) RHODAMINE 123(DULL) CELLS

      Experimental hematology
    73. SROUR EF; KOSAK ST; GRIGSBY S; TRAYCOFF CM
      EVALUATION OF THE HEMATOPOIETIC POTENTIAL OF EX-VIVO EXPANDED MARROW AND CORD-BLOOD PROGENITOR CELLS USING CELL TRACKING AND LIMITING DILUTION ANALYSIS

      Experimental hematology
    74. BROUN ER; TRAYCOFF CM; GRAVES V; LAW P; SLEDGE GW; MILLS B; OLDHAM F; SROUR EF
      COMPARISON OF ENGRAFTMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EITHER FULL BONE-MARROW OR CD34-ISOLEX-300(TM)( CELLS ISOLATED WITH THE BAXTER)

      Experimental hematology
    75. SROUR EF; SIENA S; BREGNI M; KOSAK S; TRAYCOFF CM; GRIGSBY S; GIANNI AM
      LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS MOBILIZED INTO PERIPHERAL-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES DO NOT UNDERGO ADDITIONAL EX-VIVO EXPANSION

      Experimental hematology
    76. TRAYCOFF CM; BROUN ER; BURGESS J; GRAVES V; LAW P; SLEDGE GW; MILLS B; SROUR EF
      EVALUATION OF THE HEMATOPOIETIC POTENTIAL OF CD34 ENRICHED AUTOLOGOUSBONE-MARROW GRAFTS PREPARED WITH THE BAXTER ISOLEX 300(TM)

      Experimental hematology
    77. SROUR EF
      HEMATOPOIETIC GROWTH-FACTORS AND TRANSENDOTHELIAL MIGRATION

      Experimental hematology
    78. TRAYCOFF CM; ABBOUD MR; LAVER J; BRANDT JE; HOFFMAN R; LAW P; ISHIZAWA L; SROUR EF
      EVALUATION OF THE IN-VITRO BEHAVIOR OF PHENOTYPICALLY DEFINED POPULATIONS OF UMBILICAL-CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS

      Experimental hematology
    79. TRAYCOFF CM; ABBOUD MR; LAVER J; CLAPP DW; SROUR EF
      RAPID EXIT FROM G(0) G(1) PHASES OF CELL-CYCLE IN RESPONSE TO STEM-CELL FACTOR CONFERS ON UMBILICAL-CORD BLOOD CD34(+) CELLS AN ENHANCED EX-VIVO EXPANSION POTENTIAL/

      Experimental hematology
    80. TONG J; HOFFMAN R; SIENA S; SROUR EF; BREGNI M; GIANNI AM
      CHARACTERIZATION AND QUANTITATION OF PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS PRESENT IN PERIPHERAL-BLOOD AUTOGRAFTS

      Experimental hematology
    81. SILVA MRG; HOFFMAN R; SROUR EF; ASCENSAO JL
      GENERATION OF HUMAN NATURAL-KILLER-CELLS FROM IMMATURE PROGENITORS DOES NOT REQUIRE MARROW STROMAL CELLS

      Blood
    82. TRAYCOFF CM; GRIGSBY S; SROUR EF
      PROGRESSIVE DECLINE OF THE FREQUENCY OF LONG-TERM HEMATOPOIETIC CULTURE-INITIATING CELLS IN EX-VIVO EXPANDED CD34+ PROGENITOR CELLS CORRELATES WITH THE NUMBER OF CELLULAR DIVISIONS IN CULTURE

      Blood
    83. TRAYCOFF CM; SIENA S; BREGNI M; GIANNI AM; SROUR EF
      KINETICS AND RATE OF DECLINE OF PRIMITIVE HEMATOPOIETIC FUNCTIONS AMONG EX-VIVO EXPANDED PROGENITOR CELLS ARE DIFFERENT BETWEEN BONE-MARROWCORD-BLOOD AND MOBILIZED PERIPHERAL-BLOOD CD34+ CELLS

      Blood
    84. CORNETTA K; SROUR EF; BEREBITSKY D; DAVIDSON A; MOORE A; BROUN ER; HROMAS R; MOEN RC; MORGAN RA; ANDERSON WF; HOFFMAN R; TRICOT G
      RETROVIRAL MARKING OF AUTOLOGOUS BONE-MARROW GRAFTS IN ADULT ACUTE-LEUKEMIA

      Blood
    85. RIGDEN J; CORNETTA K; BAUTE J; BROUN ER; CUNNINGHAM I; HEDDERMAN A; HROMAS R; MENKE C; RUBIN L; SROUR EF; TRICOT G
      EXCELLENT ENGRAFTMENT WITHOUT GRAFT-VERSUS-HOST DISEASE OR VENOOCCLUSIVE DISEASE IN T-CELL DEPLETED SIBLING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANT

      Blood
    86. HOFFMAN R; TONG J; BRANDT J; TRAYCOFF C; BRUNO E; MCGUIRE BW; GORDON MS; MCNIECE I; SROUR EF
      THE IN-VITRO AND IN-VIVO EFFECTS OF STEM-CELL FACTOR ON HUMAN HEMATOPOIESIS

      Stem cells
    87. TONG J; GORDON MS; SROUR EF; COOPER RJ; MCNIECE I; HOFFMAN R
      THE IN-VIVO ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (SCF) EXPANDS THE NUMBER OF HUMAN MARROW HEMATOPOIETIC STEM-CELLS (HSC)

      Experimental hematology
    88. CORNETTA K; HOFFMAN R; MOORE A; EDER P; SROUR EF
      RETROVIRAL TRANSDUCTION OF HUMAN BONE-MARROW CD34(-DR(-) CD15(-) HEMATOPOIETIC PROGENITOR CELLS() HLA)

      Experimental hematology
    89. TRAYCOFF C; ABBOUD MR; LAVER J; CLAPP DW; BRANDT JE; HOFFMAN R; SROUR EF
      HUMAN UMBILICAL-CORD BLOOD CD34(-DR(+) CELLS RESIDE IN A DEEPER DORMANCY STATE AND EXIT G(0)() HLA)G(1) PHASES OF CELL-CYCLE QUICKER THAN THEIR BM COUNTERPARTS/

      Experimental hematology
    90. HOFFMAN R; TONG J; SIENA S; SROUR EF; BREGNI M; GIANNI AM
      EXAMINATION OF THE HEMATOPOIETIC PROGENITOR-CELL AND STEM-CELL CONTENT OF HUMAN PERIPHERAL-BLOOD AUTOGRAFTS MOBILIZED WITH HIGH-DOSE CYCLOPHOSPHAMIDE FOLLOWED BY GROWTH-FACTOR COMBINATIONS

      Experimental hematology
    91. SROUR EF; TONG J; EDER P; BREGNI M; SIENA S; GIANNI AM; HOFFMAN R
      NUMBERS OF HUMAN CD34(-BLOOD WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND RECOMBINANT CYTOKINES INCREASE IN-VITRO FOLLOWING A SHORT EXPOSURE TO STEM-CELL FACTOR() HEMATOPOIETIC PROGENITOR CELLS MOBILIZED INTO PERIPHERAL)

      Experimental hematology
    92. SROUR EF; ZANJANI ED; TRAYCOFF CM; CORNETTA K; HOFFMAN R
      IDENTIFICATION OF A COMMON NATURAL-KILLER (NK) CELL-T-LYMPHOCYTE-BETA-LYMPHOCYTE PROGENITOR-CELL IN ADULT HUMAN BONE-MARROW (BM)

      The Journal of immunology
    93. CORNETTA K; TRICOT G; SROUR EF; HROMAS R; BROUN ER; CUNNINGHAM I; HEDDERMAN A; HOFFMAN R
      RETROVIRAL GENE MARKING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Clinical research
    94. KELLER DC; DU XX; SROUR EF; HOFFMAN R; WILLIAMS DA
      INTERLEUKIN-11 INHIBITS ADIPOGENESIS AND STIMULATES MYELOPOIESIS IN HUMAN LONG-TERM MARROW CULTURES

      Blood
    95. TONG J; GORDON MS; SROUR EF; COOPER RJ; ORAZI A; MCNIECE I; HOFFMAN R
      IN-VIVO ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR EXPANDS THE NUMBER OF HUMAN MARROW HEMATOPOIETIC STEM-CELLS

      Blood
    96. SROUR EF; ZANJANI ED; CORNETTA K; TRAYCOFF CM; FLAKE AW; HEDRICK M; BRANDT JE; LEEMHUIS T; HOFFMAN R
      PERSISTENCE OF HUMAN MULTILINEAGE, SELF-RENEWING LYMPHOHEMATOPOIETIC STEM-CELLS IN CHIMERIC SHEEP

      Blood
    97. TRAYCOFF C; ABBOUD MR; LAVER J; CLAPP DW; HOFFMAN R; SROUR EF
      INCREASED RESPONSE OF QUIESCENT UMBILICAL-CORD BLOOD HEMATOPOIETIC PROGENITOR CELLS TO SCF RESULTS IN AN ENHANCED EXPANSION OF CD34-VITRO( CELLS IN)

      Blood
    98. CORNETTA K; BAUTE J; BROUN ER; CUNNINGHAM I; HEDDERMAN A; HROMAS R; KNEEBONE P; RUBIN L; SROUR EF; TRICOT G
      PREVENTION OF GRAFT-REJECTION IN T-CELL DEPLETED BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS

      Blood
    99. GRIGSBY S; TRICOT G; LEEMHUIS T; TRAYCOFF C; CORNETTA K; EDER P; ADAMS D; HOFFMAN R; SROUR EF
      ANALYSIS OF CORRELATIONS BETWEEN CD34-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION PATIENTS( CELL CONTENT OF MARROW GRAFTS AND CLINICAL OUTCOME IN T)

      Blood
    100. PAYNE TA; TRAYCOFF C; ABBOUD MR; SROUR EF; XU F; HOFFMAN R; LAVER J
      CD34-BLOOD CORRELATE WITH THE NUMBER OF CLONOGENIC PROGENITORS( CELL NUMBERS IN CORD)

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 23:36:09